A recent investigation has raised questions about pharmaceutical companies potentially saving crores by conducting clinical trials at government-run hospitals like VS Hospital in Ahmedabad. These trials, which are crucial for testing the efficacy and safety of new drugs, are typically conducted at private hospitals or research centers. However, the investigation found that several pharma companies opted to conduct these trials at VS Hospital, a government facility, which raised concerns about the quality and ethics of the trials. While conducting trials at government hospitals may save money for pharmaceutical companies, it also raises questions about the integrity of the research and the safety of the participants. The investigation highlighted the need for stricter regulations and oversight of clinical trials in India to ensure that they are conducted ethically and in accordance with international standards. It also underscored the importance of transparency in the pharmaceutical industry to maintain public trust and confidence. As India continues to be a hub for clinical trials due to its large and diverse population, it is imperative that the government and regulatory bodies take steps to ensure the safety and integrity of these trials. In light of these findings, it is essential for pharmaceutical companies to prioritize ethical practices and patient safety in their research endeavors.